Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic
  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Taysha Gene Therapies to Participate in Upcoming August Investor Healthcare Conferences

BTIG Virtual Biotechnology Conference on August 9, 2021 at 11:30 am ET

2021 Wedbush Pacgrow Healthcare Virtual Conference on August 11, 2021 at 8:35 am ET

Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivitol-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its participation in a fireside chat for the BTIG Virtual Biotechnology Conference and a panel for the 2021 Wedbush Pacgrow Healthcare Virtual Conference.

Conferences Details:

Event:

BTIG Virtual Biotechnology Conference

Date:

Monday August 9, 2021

Time:

11:30 am ET

Format:

Fireside chat

Participants:

RA Session II, President, Founder and CEO

 

Dr. Suyash Prasad, Chief Medical Officer and Head of R&D

 

Kamran Alam, Chief Financial Officer

 

 

Event:

2021 Wedbush Pacgrow Healthcare Virtual Conference

Date:

Wednesday August 11, 2021

Time:

8:35 am ET

Format:

Panel discussion

Participants:

RA Session II, President, Founder and CEO

Webcasts for these conferences will be available in the “Events & Media” section of the Taysha corporate website at https://ir.tayshagtx.com/news-events/events-presentations. Archived versions of the webcasts will be available on the website for 60 days.

About Taysha Gene Therapies

Taysha Gene Therapies (Nasdaq: TSHA) is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we aim to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications. Together, we leverage our fully integrated platform—an engine for potential new cures—with a goal of dramatically improving patients’ lives. More information is available at www.tayshagtx.com.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.